About the invention
The TSPO (18 kDa) is a model developed at ANSTO in collaboration with The University of Sydney. Learn more.
Research published in Nature Communications heralds a scientific breakthrough that could be the key to the development of better diagnostics and new treatments for conditions such as multiple sclerosis, dementia, cancer and obesity.
The TSPO (18 kDa) is a model developed at ANSTO in collaboration with The University of Sydney. Learn more.
TSPO is a protein that is associated with crucial cellular functions including the activity of the mitochondria. Learn more.
ANSTO is a world leader in medical isotope research and application with a strong history of research and development of synthetic ligands. Learn more.
The TSPO knockout has a wide variety of potential applications across various disease states. Learn more.
ANSTO is now accepting expressions of interest for partnership opportunities to accelerate the potential for discovery. Learn more.
You can read the published version of the journal article as it appears in Nature Communications. Learn more.
